NASDAQ:EYE National Vision - EYE Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding National Vision Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $17.65 -0.04 (-0.23%) (As of 03/28/2023 12:00 AM ET) Add Compare Share Share Today's Range$17.57▼$18.0650-Day Range$17.28▼$43.4352-Week Range$17.25▼$45.86Volume1.69 million shsAverage Volume1.34 million shsMarket Capitalization$1.39 billionP/E Ratio36.02Dividend YieldN/APrice Target$32.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability National Vision MarketRank™ ForecastAnalyst RatingModerate Buy2.83 Rating ScoreUpside/Downside81.3% Upside$32.00 Price TargetShort InterestHealthy7.04% of Float Sold ShortDividend StrengthN/ASustainability-1.35Upright™ Environmental ScoreNews Sentiment0.25Based on 11 Articles This WeekInsider TradingSelling Shares$55,760 Sold Last QuarterProj. Earnings Growth46.81%From $0.47 to $0.69 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.90 out of 5 starsMedical Sector43rd out of 1,002 stocksOphthalmic Goods Industry2nd out of 7 stocks 4.4 Analyst's Opinion Consensus RatingNational Vision has received a consensus rating of Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $32.00, National Vision has a forecasted upside of 81.3% from its current price of $17.65.Amount of Analyst CoverageNational Vision has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 3.0 Short Interest Percentage of Shares Shorted7.04% of the float of National Vision has been sold short.Short Interest Ratio / Days to CoverNational Vision has a short interest ratio ("days to cover") of 4.5.Change versus previous monthShort interest in National Vision has recently decreased by 22.96%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldNational Vision does not currently pay a dividend.Dividend GrowthNational Vision does not have a long track record of dividend growth. Previous Next 3.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreNational Vision has received a 37.34% net impact score from Upright. National Vision seems to create the most significant positive value in categories "Jobs", "Taxes", and "Physical diseases". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Private optician services", "Physical retail of eyeglasses at an optician store", and "Physical retail of contact lenses at an optician store" products. See details.Environmental SustainabilityThe Environmental Impact score for National Vision is -1.35. Previous Next 2.4 News and Social Media Coverage News SentimentNational Vision has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for National Vision this week, compared to 5 articles on an average week.Search Interest10 people have searched for EYE on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added National Vision to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, National Vision insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $55,760.00 in company stock.Percentage Held by InsidersOnly 1.70% of the stock of National Vision is held by insiders. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for National Vision are expected to grow by 46.81% in the coming year, from $0.47 to $0.69 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of National Vision is 36.02, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 119.24.Price to Earnings Ratio vs. SectorThe P/E ratio of National Vision is 36.02, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 111.78.Price to Earnings Growth RatioNational Vision has a PEG Ratio of 1.91. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioNational Vision has a P/B Ratio of 1.55. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About National Vision (NASDAQ:EYE) StockNational Vision Holdings, Inc. engages in the retail of optical products. It operates through the following segments: Owned and Host, Legacy, and Corporate/Other. The Owned and Host segment offers America's Best and Eyeglass World brands. The Legacy segment includes inventory and lab processing services. The Corporate/Other segment consists of the results of operations of the other operating segments and corporate overhead support. The company was founded in 1990 and is headquartered in Duluth, GA.Read More Receive EYE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Vision and its competitors with MarketBeat's FREE daily newsletter. Email Address EYE Stock News HeadlinesMarch 28, 2023 | msn.comFujifilm India launches CAD EYE function for Upper Gastrointestinal diagnosis at GI Update 2023March 27, 2023 | marketwatch.comDEADLINE TOMORROW: The Schall Law Firm Encourages Investors in National Vision Holdings, Inc. with Losses of $100,000 to Contact the FirmMarch 28, 2023 | Investor Place Media (Ad)Biden To Unleash "Choke Point" Operation On America?Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.March 27, 2023 | businesswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against National Vision Holdings, Inc. (EYE)March 27, 2023 | americanbankingnews.comBrokerages Set National Vision Holdings, Inc. (NASDAQ:EYE) Price Target at $32.00March 25, 2023 | msn.comQuestions About Eye Donating? Read These Insightful AnswersMarch 23, 2023 | msn.comThese Eye Drop Brands Were Recalled, Due to Possible Bacterial ContaminationMarch 22, 2023 | finance.yahoo.comNational Vision Holdings, Inc.'s (NASDAQ:EYE) Intrinsic Value Is Potentially 30% Above Its Share PriceMarch 28, 2023 | Investor Place Media (Ad)Biden To Unleash "Choke Point" Operation On America?Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.March 21, 2023 | msn.comEye patients going blind because of NHS backlog delaysMarch 14, 2023 | msn.comWhat Does It Mean If You Have Two Pupils In One Eye?March 9, 2023 | msn.com10 inspiring Barbies to boost your motivation on National Barbie DayMarch 8, 2023 | msn.comRepublicans eye transformational cuts as Biden seeds a tax hike. Nobody will get exactly what they wantMarch 8, 2023 | finance.yahoo.comNational Vision Holdings, Inc. (NASDAQ:EYE) Q4 2022 Earnings Call TranscriptMarch 8, 2023 | finance.yahoo.comNational Vision Names 2022-2023 Scholarship Program Winners, Giving $12,500 to Next Generation of ODsMarch 7, 2023 | msn.comEYE vs. RMD: Which Stock Should Value Investors Buy Now?March 3, 2023 | markets.businessinsider.comWhere National Vision Holdings Stands With AnalystsMarch 2, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Consumer Goods Stocks: Tesla (TSLA), National Vision Holdings (EYE)March 2, 2023 | finance.yahoo.comQ4 2022 National Vision Holdings Inc Earnings CallMarch 1, 2023 | seekingalpha.comNational Vision Holdings plummets over 30% on wider than expected lossMarch 1, 2023 | finance.yahoo.comNational Vision stock plunges toward record selloff on heavy volume after disappointing results and outlook, but one analyst says selloff is ‘overly harsh’March 1, 2023 | finance.yahoo.comWhy National Vision Stock Crashed and Burned WednesdayMarch 1, 2023 | msn.comNational Vision Holdings's Earnings: A PreviewMarch 1, 2023 | markets.businessinsider.comNational Vision Q4 Results Miss Estimates; Sees FY Profit Below View - Quick FactsMarch 1, 2023 | msn.comNational Vision (EYE) Reports Q4 Loss, Misses Revenue EstimatesMarch 1, 2023 | finance.yahoo.comNational Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2022 Financial ResultsFebruary 28, 2023 | msn.comHow a Rare Eye Disease Caused My BlindnessSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive EYE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Vision and its competitors with MarketBeat's FREE daily newsletter. Email Address EYE Company Calendar Last Earnings3/01/2023Today3/28/2023Next Earnings (Estimated)5/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Ophthalmic goods Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:EYE Previous SymbolNYSE:EYE CUSIPN/A CIK1710155 Webwww.nationalvision.com Phone(770) 822-3600FaxN/AEmployees13,975Year FoundedN/APrice Target and Rating Average Stock Price Forecast$32.00 High Stock Price Forecast$45.00 Low Stock Price Forecast$24.00 Forecasted Upside/Downside+79.6%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)$0.49 Trailing P/E Ratio36.37 Forward P/E Ratio37.91 P/E Growth1.91Net Income$42.12 million Net Margins2.10% Pretax Margin3.03% Return on Equity4.16% Return on Assets1.65% Debt Debt-to-Equity Ratio0.63 Current Ratio1.38 Quick Ratio1.02 Sales & Book Value Annual Sales$2.01 billion Price / Sales0.70 Cash Flow$1.87 per share Price / Cash Flow9.54 Book Value$11.42 per share Price / Book1.56Miscellaneous Outstanding Shares79,000,000Free Float77,653,000Market Cap$1.41 billion OptionableOptionable Beta1.50 Key ExecutivesL. Reade FahsChief Executive Officer & DirectorPatrick R. MooreChief Operating Officer & Senior Vice PresidentMelissa RasmussenChief Financial Officer & Senior Vice PresidentRavi AcharyaChief Technology Officer & Senior Vice PresidentJared BrandmanSecretary, Senior Vice President & General CounselKey CompetitorsWarby ParkerNYSE:WRBYRxSightNASDAQ:RXSTSTAAR SurgicalNASDAQ:STAARocket PharmaceuticalsNASDAQ:RCKTPROCEPT BioRoboticsNASDAQ:PRCTView All CompetitorsInsiders & InstitutionsTeachers Retirement System of The State of KentuckySold 2,405 shares on 2/22/2023Ownership: 0.031%Macquarie Group Ltd.Bought 73,759 shares on 2/21/2023Ownership: 3.595%Alliancebernstein L.P.Sold 128,823 shares on 2/16/2023Ownership: 5.927%State of WyomingBought 2,563 shares on 2/16/2023Ownership: 0.003%Public Employees Retirement System of OhioSold 1,935 shares on 2/15/2023Ownership: 0.001%View All Insider TransactionsView All Institutional Transactions EYE Stock - Frequently Asked Questions Should I buy or sell National Vision stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for National Vision in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" EYE shares. View EYE analyst ratings or view top-rated stocks. What is National Vision's stock price forecast for 2023? 6 brokers have issued 1-year price targets for National Vision's stock. Their EYE share price forecasts range from $24.00 to $45.00. On average, they anticipate the company's stock price to reach $32.00 in the next year. This suggests a possible upside of 79.6% from the stock's current price. View analysts price targets for EYE or view top-rated stocks among Wall Street analysts. How have EYE shares performed in 2023? National Vision's stock was trading at $38.76 at the start of the year. Since then, EYE shares have decreased by 54.0% and is now trading at $17.82. View the best growth stocks for 2023 here. Are investors shorting National Vision? National Vision saw a decline in short interest in March. As of March 15th, there was short interest totaling 5,470,000 shares, a decline of 23.0% from the February 28th total of 7,100,000 shares. Based on an average daily trading volume, of 1,220,000 shares, the days-to-cover ratio is presently 4.5 days. Currently, 7.0% of the company's stock are short sold. View National Vision's Short Interest. When is National Vision's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023. View our EYE earnings forecast. How were National Vision's earnings last quarter? National Vision Holdings, Inc. (NASDAQ:EYE) issued its earnings results on Wednesday, March, 1st. The company reported ($0.11) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.11). The firm earned $468.93 million during the quarter, compared to the consensus estimate of $471.61 million. National Vision had a trailing twelve-month return on equity of 4.16% and a net margin of 2.10%. What ETFs hold National Vision's stock? ETFs with the largest weight of National Vision (NASDAQ:EYE) stock in their portfolio include Invesco S&P SmallCap Consumer Discretionary ETF (PSCD), SPDR S&P Retail ETF (XRT), Direxion Daily Retail Bull 3X Shares (RETL), Vanguard S&P Small-Cap 600 Growth ETF (VIOG), Vanguard S&P Small-Cap 600 ETF (VIOO), Vanguard S&P Small-Cap 600 Value ETF (VIOV), Franklin U.S. Small Cap Multifactor Index ETF (FLQS) and iShares S&P Small-Cap 600 Growth ETF (IJT). How will National Vision's stock buyback program work? National Vision announced that its board has initiated a share buyback program on Monday, November 29th 2021, which allows the company to repurchase $100,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to reacquire up to 2.5% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's leadership believes its shares are undervalued. What guidance has National Vision issued on next quarter's earnings? National Vision issued an update on its FY 2023 earnings guidance on Wednesday, March, 1st. The company provided earnings per share (EPS) guidance of $0.42-$0.60 for the period, compared to the consensus EPS estimate of $0.98. The company issued revenue guidance of $2.08 billion-$2.13 billion, compared to the consensus revenue estimate of $2.14 billion. What is L. Reade Fahs' approval rating as National Vision's CEO? 243 employees have rated National Vision Chief Executive Officer L. Reade Fahs on Glassdoor.com. L. Reade Fahs has an approval rating of 97% among the company's employees. This puts L. Reade Fahs in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of National Vision own? Based on aggregate information from My MarketBeat watchlists, some companies that other National Vision investors own include Verizon Communications (VZ), Enterprise Products Partners (EPD), AT&T (T), Carnival Co. & (CCL), Antares Pharma (ATRS), Advanced Micro Devices (AMD), Gilead Sciences (GILD), QUALCOMM (QCOM), Tanger Factory Outlet Centers (SKT) and STMicroelectronics (STM). When did National Vision IPO? (EYE) raised $300 million in an initial public offering on Thursday, October 26th 2017. The company issued 15,800,000 shares at $18.00-$20.00 per share. BofA Merrill Lynch, Goldman Sachs, Citigroup, KKR, Morgan Stanley, Jefferies, UBS Investment Bank and Wells Fargo Securities acted as the underwriters for the IPO and Guggenheim Securities, Mizuho Securities and Macquarie Capital were co-managers. What is National Vision's stock symbol? National Vision trades on the NASDAQ under the ticker symbol "EYE." Who are National Vision's major shareholders? National Vision's stock is owned by a number of retail and institutional investors. Top institutional investors include JPMorgan Chase & Co. (9.72%), William Blair Investment Management LLC (8.75%), Alliancebernstein L.P. (5.93%), Clearbridge Investments LLC (5.37%), Macquarie Group Ltd. (3.59%) and Dimensional Fund Advisors LP (2.01%). Insiders that own company stock include Jared Brandman, L Reade Fahs, Melissa Rasmussen, Mfn Partners, Lp, Ravi Acharya and Virginia A Hepner. View institutional ownership trends. How do I buy shares of National Vision? Shares of EYE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is National Vision's stock price today? One share of EYE stock can currently be purchased for approximately $17.82. How much money does National Vision make? National Vision (NASDAQ:EYE) has a market capitalization of $1.41 billion and generates $2.01 billion in revenue each year. The company earns $42.12 million in net income (profit) each year or $0.49 on an earnings per share basis. How many employees does National Vision have? The company employs 13,975 workers across the globe. How can I contact National Vision? National Vision's mailing address is 2435 COMMERCE AVENUE BLDG. 2200, DULUTH GA, 30096. The official website for the company is www.nationalvision.com. The company can be reached via phone at (770) 822-3600 or via email at investor.relations@nationalvision.com. This page (NASDAQ:EYE) was last updated on 3/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.